SIMON MCCLURE: Open Payments
NPI 1386677813 · BRIDGEPORT, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,818 in 147 payments from 18 companies in 2025. Trend: 2023 $4,392 · 2024 $2,728 · 2025 $3,818
Food & beverage: $3,818
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 22 | $1,028 |
| Neurocrine BioSciences, Inc. | 18 | $524 |
| Otsuka America Pharmaceutical, Inc. | 21 | $479 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $330 |
| Teva Pharmaceuticals USA, Inc. | 19 | $297 |
| Alkermes, Inc. | 2 | $233 |
| ABBVIE INC. | 15 | $167 |
| Corium, LLC | 7 | $162 |
| Lundbeck LLC | 6 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
Products named: FANAPT, REXULTI, INGREZZA, CAPLYTA, AUSTEDO XR, LYBALVI, VRAYLAR, Azstarys.
Industry payments across WV — which companies pay providers there.
